Stratec Se

Stratec Se Book Value per Share

The Book Value per Share of Stratec Se (SBS.DE) as of Oct 9, 2026 is 19.52 EUR. In the previous year, Book Value per Share was 19.95 EUR — a change of -2.15% (lower).

Book Value per Share

19.52EUR

YoY

-2.15%

Last updated:

Book Value per Share of Stratec Se is 2025 19.52 EUR. Book Value per Share of Stratec Se was 2024 19.95 EUR. It decreases by -2.15% lower compared to the previous year.

The Stratec Se Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
12.52 EUR
Jan 1, 2019
13.08 EUR
Jan 1, 2020
14.19 EUR
Jan 1, 2021
16.93 EUR
Jan 1, 2022
18.52 EUR
Jan 1, 2023
19.19 EUR
Jan 1, 2024
19.95 EUR
Jan 1, 2025
19.52 EUR
The Stratec Se Book Value per Share history
YEARBook Value per ShareYoY
19.52EUR-2.15%
19.95EUR+3.95%
19.19EUR+3.62%
18.52EUR+9.44%
16.93EUR+19.25%
14.19EUR+8.51%
13.08EUR+4.47%
12.52EUR-3.57%
12.98EUR+9.82%
11.82EUR+10.32%
10.72EUR+16.27%
9.22EUR—
Access this data via the Eulerpool API

Stratec Se Stock analysis

What does Stratec Se do? The company Stratec SE is a German company operating in the medical technology industry. It was founded in 1984 and has since become a leading provider of automation solutions and diagnostic instruments. Stratec's business model is based on the development and production of devices and systems used in medical diagnostics. The company focuses in particular on the areas of immunology, clinical chemistry, and hematology. Stratec also offers innovative solutions in microscopy and cell analysis. In the "automation solutions" division, Stratec develops systems for the automation of laboratory processes. These are mainly used in clinical diagnostics to accelerate and simplify workflow. Examples include sample identification systems, pipetting robots, and analysis devices. In the "in vitro diagnostics" division, Stratec offers products for determining blood values. This includes devices for determining glucose, cholesterol, and hemoglobin levels, as well as devices for infection diagnostics and tumor and allergy diagnostics. Another division of Stratec is "microscopy." The company manufactures automated microscope systems, primarily used in biomedical research to analyze cells and tissues. In the "cell analysis" division, Stratec offers innovative methods for analyzing cells, such as cell growth and vitality determination. Stratec always focuses on tailoring the design of its products to the needs of its customers. High flexibility in device development and manufacturing is therefore an important factor in the company's success. In addition to device development and production, Stratec also provides services related to its products. These include installation, maintenance, and on-site repair of devices for customers. Stratec SE operates internationally and has branches in Europe, Asia, and America. The company employs over 1,000 people worldwide. Overall, Stratec SE is a successful and renowned provider of medical devices and systems for automating laboratory processes. With its diverse product portfolio and high flexibility in customer support, Stratec has earned a leading position in the industry. Stratec Se is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stratec Se stock

Book Value per Share of Stratec Se is 19.52 EUR in 2025.

Book Value per Share of Stratec Se changed from 19.95 EUR to 19.52 EUR, representing a -2.15% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Stratec Se since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

Balance Sheet — Stratec Se

All Key Metrics — Stratec Se